Designing allosteric modulators to change GPCR G protein subtype selectivity
Open Access
- 22 October 2025
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 648 (8092) , 229-238
Abstract
G-protein-coupled receptors (GPCRs) convert extracellular signals into intracellular responses by signalling through 16 subtypes of Gα proteins and two β-arrestin proteins. Biased compounds—molecules that preferentially activate a subset of these proteins—engage therapy-relevant pathways more selectively1 and promise to be safer, more effective medications than compounds that uniformly activate all pathways2. However, the determinants of bias are poorly understood, and we lack rationally designed molecules that select for specific G proteins. Here, using the prototypical class A GPCR neurotensin receptor 1 (NTSR1), we show that small molecules that bind to the intracellular GPCR–transducer interface change G protein coupling by subtype-specific and predictable mechanisms, enabling structure-guided drug design. We find that the intracellular, core-binding compound SBI-553 switches the G protein preference of NTSR1 through direct intermolecular interactions3,4,5, promoting or preventing association with specific G protein subtypes. Modifications to the SBI-553 scaffold produce allosteric modulators with distinct G protein selectivity profiles. Selectivity profiles are probe independent, conserved across species and translate to differences in activity in vivo. Our studies show that G protein selectivity can be tailored with small changes to a single chemical scaffold targeting the receptor–transducer interface. Moreover, given that this pocket is broadly conserved, our findings could provide a strategy for pathway-selective drug discovery that is applicable to the diverse GPCR superfamily.Keywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painCell, 2025
- Biased allosteric modulator of neurotensin receptor 1 reduces ethanol drinking and responses to ethanol administration in rodentsAddiction Neuroscience, 2024
- Rules and mechanisms governing G protein coupling selectivity of GPCRsCell Reports, 2023
- Location bias: A “Hidden Variable” in GPCR pharmacologyBioEssays, 2023
- Subtype-dependent regulation of Gβγ signallingCellular Signalling, 2021
- β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsCell, 2020
- Reduced amide bond neurotensin 8–13 mimetics with potent in vivo activityBioorganic & Medicinal Chemistry Letters, 1995
- Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slicesBrain Research, 1984
- Hypothermia elicited by the intracerebral microinjection of neurotensinPeptides, 1980